Biomaterials have long been explored in regenerative medicine strategies for repair or replacement of damaged organs and tissues. However, poor adhesion under wet conditions (like those found in tissues) has thus far limited their wider application. Indeed, despite its favourable physicochemical properties, facile gelation and biocompatibility, gellan gum (GG)-based hydrogels lack the tissue adhesiveness required for effective clinical use. Aiming at assessing whether substitution of GG by dopamine (DA) could be a suitable approach to overcome this problem, database searches were conducted on PubMed® and Embase® up to 02 March 2021, for studies using biomaterials covalently modified with a catechol-containing substituent conferring improved adhesion properties. In this regard, a total of 47 reports (out of 700 manuscripts, ~ 6.7%) were found to comply with the search/selection criteria, the majority of which (34/47, ~ 72%) describing modification of natural polymers, such as chitosan (11/47, ~ 23%) and hyaluronic acid (6/47, ~ 13%); conjugation of dopamine (as catechol “donor”) via carbodiimide coupling chemistry was also predominant. Overall, there is ample literature evidence that bio-inspired substitution of polymers of natural and synthetic origin by DA or other catechol moieties greatly improves adhesion to biological tissues.
Biomaterial adhesion in wet environments is significantly impacted by the presence of water molecules, with a widely recognised decrease in adhesion strength due to (i) formation of a hydration layer in the biomaterial/tissue interface which limits the contact between molecules, (ii) water interference with the electrostatic and hydrophobic interactions between biomaterials and tissues, and (iii) swelling of the biomaterials leading to weakened adhesive forces [59].
Several strategies can be employed to minimise these adverse effects, including optimisation of biomaterial surfaces to decrease hydrophilicity/wettability (and therefore decrease the number of water molecules bound to the surfaces) and fine-tuning of biomaterial viscosity to increased formation of interlocking structures with tissues, which are less prone to be affected by water. Indeed, high underwater adhesion has been reported for biomaterials capable of establishing strong interlocking structures with wet substrates. Suo et al. [60] described the preparation of slug-inspired tough adhesives (TAs), combining alginate and a bridging polymer in a 2-layer structure, which displayed high adhesion strength mediated by strong interlocking interactions between adhesive and substrate, as well as energy dissipation through hysteresis. Specialised adhesive structures are also found in nature, especially in animals or microorganisms living in wet conditions or requiring movements in extreme plans (e.g., keratin foot-hairs lining the sole of gecko’s feet), which rely on micro-topography cues for enhanced adhesivity to surrounding surfaces [61].
To date, however, mussels constitute the largest source of inspiration for development of adhesives with improved wet adhesive strength, as confirmed by the findings of this literature review. Indeed, catechol-conjugated, tissue-adhesive polymers with tunable physical and mechanical properties have been described for a range of natural origin biomolecules including (i) polysaccharides such as chitosan, hyaluronic acid, alginate, dextran, cellulose, xanthan gum, gellan gum, and (ii) proteins such as gelatin and silk fibroin, as well as synthetic polymers such as polyethylene glycol (PEG) and cyanoacrylate derivatives. The common theme of all articles reviewed herein centres around the desire to improve adhesion of hydrogels prepared from such polymers to soft and hard tissues or surfaces for application in tissue engineering and regenerative medicine.
Overall, there is sufficient weight of evidence that the chemical modification of biomaterials with dopamine (DA) or other catechol-containing substituents leads to a viable semi-synthetic approach for mimicking marine-inspired bioadhesion processes found in nature and provides substantial improvement over the properties of the parent polymer.
In addition to the impact of catechol modification on adhesivity, this review also allowed harnessing additional information which imparts further incentive for modification of biomaterials with catechol moieties, namely:
Based on the above listed findings, it was anticipated that the same observations would apply to GG once substituted by DA. Indeed, in our own published study [62] (which is included in the list of selected manuscripts), a mussel-inspired DA-modified GG hydrogel was designed for minimally-invasive delivery in cartilage repair procedures. Aiming at improving on GG limitations, including low aqueous solubility and poor adhesivity, the parent polymer was initially purified to a monovalent sodium salt form (GGp) and further functionalised with DA upon activation of carboxylic groups with 4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methylmorpholinium chloride (DTMMCI) (DS = 4.7 %). DA-modified GGp (STM-148B) solutions (1 % w/V in water) displayed a favourable shear-thinning profile (i.e., decreasing in solution viscosity over the shear rate 0.01 – 1000 s-1) and a dynamic mono-and divalent cation-mediated crosslinking process, with a moderate elastic profile in the first 5 min after mixing with the crosslinker (PBS Ca2+/Mg2+), followed by a significant G’ increase after hydrogel submersion in NaCl (0.9 % (w/V)), reaching an equilibrium after 10 min. Similarly, G’ > G’’ was found for STM-148B hydrogels for all tested frequencies. Moreover, STM-148B hydrogels displayed suitable water retention and swelling capacity (140 % of initial volume), crosslinker dependent porosity, and improved adhesiveness to cartilage defects created in porcine knee, compared to GGp or photo-crosslinked methacrylated GG. Extensive in vitro studies were carried out to characterise the biological performance of STM-148B hydrogels, with cytotoxicity assays revealing no significant toxicity of hydrogel extracts towards L-929 mouse fibroblasts, primary ovine knee chondrocytes, human nasal chondrocytes (hNCs) and human adipose-derived MSCs (hASCs). Moreover, STM-148B hydrogels effectively maintained viability of encapsulated hNCs or hASCs for up to 21 days in culture, while supporting the production of ECM components (including collagen II, aggrecan and proteoglycans) by encapsulated hASCs upon stimulation with chondrogenic differentiation factors. Subsequent in vivo proof-of-concept studies carried out in an ovine model of disease confirmed the safety and performance of the biomaterial.
Importantly, the versatility and breadth of applications for GGp is not limited to cartilage repair. In addition to DA modification (for enhanced adhesivity), our group is exploring a biomaterial-based formulation development platform for de novo synthesis of customised chemical entities, towards application in cell encapsulation/delivery and tissue regeneration (including 3D printing).
Overall, the data herein presented supports the rationale for functionalisation of naturally occurring or synthetic polymers with catechol moieties, towards the development of optimised biomaterials with improved adhesive performance in dry and (especially) wet “physiological-like” conditions. Such improvements contributed to the development of a novel generation of biomaterials, capable of surpassing commercially available tissue adhesives and wound dressings in their hemostatic potential and wound healing properties. Moreover, improved adhesion of these biomaterials has shown to be a valuable asset for controlled drug delivery systems and cell therapies that rely on the interaction with wet mucosa. Inspired by marine organisms, these innovative biomaterials show great promise in reaching clinical application by supporting improved formulation strategies of medical devices and new advanced therapy medicinal products (ATMPs) for treating life-threatening conditions such as acute bleeding or cancer, among others.